Jacqualyn A. Fouse
2020 - Agios Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $509,657 |
|---|---|
| Option Awards | $4,593,651 |
| Salary | $746,750 |
| Stock Awards | $1,751,340 |
| Other | $10,577 |
| Total | $7,611,975 |
Fouse received $4.6M in option awards, accounting for 60% of the total pay in 2020.
Fouse also received $509.7K in non-equity incentive plan, $746.8K in salary, $1.8M in stock awards and $10.6K in other compensation.
Rankings
In 2020, Jacqualyn A. Fouse's compensation ranked 1,239th out of 13,090 executives tracked by ExecPay. In other words, Fouse earned more than 90.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,239 out of 13,090 | 91st |
Division Manufacturing | 441 out of 5,621 | 92nd |
Major group Chemicals And Allied Products | 153 out of 2,254 | 93rd |
Industry group Drugs | 133 out of 1,954 | 93rd |
Industry Pharmaceutical Preparations | 96 out of 1,459 | 93rd |
Pay ratio
| Jacqualyn A. Fouse's Pay | $7,611,975 |
|---|---|
| Median Employee's Pay | $253,211 |
| Pay Ratio | 30to 1 |
In 2020, the annual total compensation of Jacqualyn A. Fouse was $7,611,975.
The annual total compensation of the median employee at Agios Pharmaceuticals was $253,211.
The ratio of Jacqualyn A. Fouse's pay to the pay of median employee was therefore 30 to one.
Fouse's colleagues
We found four more compensation records of executives who worked with Jacqualyn A. Fouse at Agios Pharmaceuticals in 2020.